triflusal has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conget, I; Coves, MJ; Esmatjes, E; Gállego, M; Maseras, M | 1 |
| Coves, MJ; Esmatjes, E; Figuerola, D; Gallego, M; Maseras, M; Ríos, M | 1 |
1 trial(s) available for triflusal and Diabetic Retinopathy
| Article | Year |
|---|---|
Effect of treatment with an inhibitor of platelet aggregation on the evolution of background retinopathy: 2 years of follow-up.
Topics: Adult; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Humans; Male; Platelet Aggregation Inhibitors; Salicylates; Visual Acuity | 1989 |
1 other study(ies) available for triflusal and Diabetic Retinopathy
| Article | Year |
|---|---|
[Effect of platelet antiaggregant treatment on the evolution of simple diabetic retinopathy. Preliminary results].
Topics: Adolescent; Adult; Diabetic Retinopathy; Drug Evaluation; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Salicylates | 1988 |